Which companies discussed GLP-1 Drugs in Health Care in earnings calls?

354 companies mentioned glp-1 drugs across 949 earnings calls in Health Care over the past year, spanning 1 sectors. The most active were West Pharmaceutical Services, Inc. (15 calls), McKesson Corporation (12 calls), Pfizer Inc. (12 calls). The table below ranks every company by how often the theme came up, with direct links to each transcript.

Mentions over time

Data table
QuarterCalls mentioning GLP-1 Drugs
2024Q4119
2025Q1241
2025Q2145
2025Q3203
2025Q4226
2026Q1274
2026Q2236
2026Q3209
2026Q4104

Companies ranked by mentions

Company Ticker Sector Calls Last mention
West Pharmaceutical Services, Inc. WST Health Care 15 Oct 29, 2026
McKesson Corporation MCK Health Care 12 Nov 4, 2026
Pfizer Inc. PFE Health Care 12 Nov 3, 2026
Wave Life Sciences Ltd. WVE Health Care 11 Nov 4, 2026
Cencora, Inc. COR Health Care 11 Nov 4, 2026
Amgen Inc. AMGN Health Care 11 Nov 3, 2026
Novo Nordisk A/S NOVOB Health Care 10 Nov 4, 2026
Inspire Medical Systems, Inc. INSP Health Care 10 Nov 2, 2026
Eli Lilly and Company LLY Health Care 10 Oct 29, 2026
Viking Therapeutics, Inc. VKTX Health Care 10 Oct 28, 2026
Fractyl Health, Inc. GUTS Health Care 10 Oct 16, 2026
Zealand Pharma A/S ZEAL Health Care 10 Sep 16, 2026
Sana Biotechnology, Inc. SANA Health Care 10 Sep 15, 2026
Mettler-Toledo International Inc. MTD Health Care 9 Nov 6, 2026
Amylyx Pharmaceuticals, Inc. AMLX Health Care 9 Nov 5, 2026
Waters Corporation WAT Health Care 9 Nov 3, 2026
Madrigal Pharmaceuticals, Inc. MDGL Health Care 9 Nov 3, 2026
Cardinal Health, Inc. CAH Health Care 8 Nov 5, 2026
Agilent Technologies, Inc. A Health Care 8 Sep 23, 2026
Rhythm Pharmaceuticals, Inc. RYTM Health Care 8 Sep 15, 2026
Altimmune, Inc. ALT Health Care 8 Aug 12, 2026
Gubra A/S GUBRA Health Care 7 Nov 6, 2026
Becton, Dickinson and Company BDX Health Care 7 Nov 5, 2026
Insulet Corporation PODD Health Care 7 Nov 4, 2026
Biocon Limited BIOCON Health Care 7 Nov 4, 2026
Amneal Pharmaceuticals, Inc. AMRX Health Care 7 Nov 3, 2026
Regeneron Pharmaceuticals, Inc. REGN Health Care 7 Oct 30, 2026
ResMed Inc. RMD Health Care 7 Oct 29, 2026
Arrowhead Pharmaceuticals, Inc. ARWR Health Care 7 Oct 14, 2026
Elanco Animal Health Incorporated ELAN Health Care 7 Sep 22, 2026
Absci Corporation ABSI Health Care 7 Sep 16, 2026
Revvity, Inc. RVTY Health Care 7 Sep 14, 2026
Amphastar Pharmaceuticals, Inc. AMPH Health Care 6 Nov 5, 2026
The Cigna Group CI Health Care 6 Nov 5, 2026
Stevanato Group S.p.A. STVN Health Care 6 Nov 3, 2026
Sandoz Group AG SDZ Health Care 6 Oct 28, 2026
Biomea Fusion, Inc. BMEA Health Care 6 Oct 13, 2026
Omada Health, Inc. OMDA Health Care 6 Sep 10, 2026
Embecta Corp. EMBC Health Care 6 Aug 7, 2026
Haleon plc HLN Health Care 6 Jul 30, 2026
Divi's Laboratories Limited DIVISLAB Health Care 5 Nov 7, 2026
AirSculpt Technologies, Inc. AIRS Health Care 5 Nov 6, 2026
CVS Health Corporation CVS Health Care 5 Nov 4, 2026
Neurocrine Biosciences, Inc. NBIX Health Care 5 Nov 2, 2026
Nxera Pharma Co., Ltd. 4565 Health Care 5 Oct 30, 2026
AstraZeneca PLC AZN Health Care 5 Oct 30, 2026
Vanda Pharmaceuticals Inc. VNDA Health Care 5 Oct 28, 2026
Mankind Pharma Limited MANKIND Health Care 5 Oct 27, 2026
Eris Lifesciences Limited ERIS Health Care 5 Oct 26, 2026
Orexo AB (publ) ORX Health Care 5 Oct 22, 2026

Representative quotes

…just add something more on towards that and the time line when we can see the commercial benefit of the GLP-1 opportunity, if you can just add anything to that, that would be helpful. Kiran Divi (Executives): I mean if you recall during my -- even during…
— Divi's Laboratories Limited (DIVISLAB), November 7, 2026. Read the full transcript →
…occupation. We also have a growth in response to the level of service and the loyalty of clients. We have trends in GLP-1. We created specific products for wellness. We have seen this in the specific products and checkups. It's still small with a small basis…
— Diagnósticos da América S.A. (DASA3), November 6, 2026. Read the full transcript →
…currently have? Are there some specific kind of test presenting better results, let's say, liver test glucose, lipid profile considering now GLP-1 analog users in Brazil, especially in the most wealthy regions of the country. Jeane Tsutsui (Executives): Thank you for the questions. You've talked…
— Fleury S.A. (FLRY3), November 6, 2026. Read the full transcript →
…does not change our conviction in the strategy or the opportunity ahead of us. 3 things reinforce that conviction. First, we performed 250 GLP-1-related procedures in the quarter, representing nearly 10% of total cases. We believe we are in the early innings of GLP-1-related…
— AirSculpt Technologies, Inc. (AIRS), November 6, 2026. Read the full transcript →

Frequently asked questions

What is GLP-1 Drugs and why are companies discussing it?

Weight-loss and diabetes drugs (Wegovy, Mounjaro, Zepbound) reshaping consumer demand, retail pharmacy economics and bioprocess equipment orders.

Which company mentioned glp-1 drugs most in Health Care in the past year?

West Pharmaceutical Services, Inc. (WST) led with 15 calls referencing glp-1 drugs, most recently on October 29, 2026.

How can I track glp-1 drugs mentions across earnings calls via API?

The EarningsCalls.dev REST API exposes the same data behind this page. Use the search_transcripts and count_mentions_by_ticker endpoints to query our archive of 33,000+ earnings call transcripts — keyword search, sector / date filters, per-company mention counts, and the underlying full transcripts. See the API docs →

Related healthcare themes

Last updated: November 7, 2026. Methodology: full-text search across all earnings call transcripts in our corpus over the past 12 months, matching the canonical term and its aliases (GLP, glp-1, glp1, glp 1). Mentions are per call, not per occurrence within a call; the company-rank table is built by counting distinct calls mentioning the theme. Page refreshes every hour at the edge as new calls land in our archive.